VORAXAZE
Peakglucarpidase
BLAINJECTIONINJECTABLEPriority Review
Approved
Jan 2012
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 3d ago
Mechanism of Action
Pharmacologic Class:
Carboxypeptidase
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
Started Mar 2019
12 enrolled
Osteosarcoma
Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL
Started Jul 2008
47 enrolled
Acute Lymphoblastic Leukemia (ALL)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.